HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
pivaloyl-S-(N'-acetylalanyl)-cysteine ethyl ester
an analog of SPM 5185 that lacks the NO moiety
Also Known As:
SPM 5267; SPM-5267
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Amino Acids, Peptides, and Proteins: 1
Peptides: 82426
Oligopeptides: 519
Dipeptides: 945
pivaloyl-S-(N'-acetylalanyl)-cysteine ethyl ester: 1
Related Diseases
1.
Myocardial Ischemia (Ischemic Heart Diseases)
09/01/1992 - "
In the myocardial ischemia (MI)+SPM-5267 group, 38 +/- 4% of the area at risk was necrotic, whereas the necrotic area/area at risk was only 7 +/- 2% in the MI+SPM-5185 group (P less than 0.01).
"
09/01/1992 - "
Intravenous administration of SPM-5185 [N-nitratopivaloyl-S-(N'-acetylalanyl)-cysteine ethyl ester], a cysteine-containing nitric oxide (NO) donor, or SPM-5267 [pivaloyl-S-(N'-acetylalanyl)-cysteine ethyl ester], an analogue of SPM-5185 that lacks the NO moiety, was studied in a feline myocardial ischemia-reperfusion model.
"
Related Drugs and Biologics
1.
pivaloyl-S-(N'-acetylalanyl)-cysteine ethyl ester
2.
Nitric Oxide (Nitrogen Monoxide)
3.
Cysteine (L-Cysteine)
4.
N- nitratopivaloyl- S- (N'- acetylalanyl)- cysteine ethyl ester
Related Therapies and Procedures
1.
Intravenous Administration